» Articles » PMID: 28861359

Intraocular Lymphoma

Overview
Specialty Ophthalmology
Date 2017 Sep 2
PMID 28861359
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Intraocular lymphoma (IOL) is a rare lymphocytic malignancy which contains two main distinct forms. Primary intraocular lymphoma (PIOL) is mainly a sub-type of primary central nervous system lymphoma (PCNSL). Alternatively, IOL can originate from outside the central nervous system (CNS) by metastasizing to the eye. These tumors are known as secondary intraocular lymphoma (SIOL). The IOL can arise in the retina, uvea, vitreous, Bruch's membrane and optic nerve. There are predominantly of B-cell origin; however there are also rare T-cell variants. Diagnosis remains challenging for ophthalmologists and pathologists, due to its ability to masquerade as noninfectious or infectious uveitis, white dot syndromes, or occasionally as other metastatic cancers. Laboratory tests include flow cytometry, immunocytochemistry, interleukin detection (IL-10: IL-6, ratio >1), and polymerase chain reaction (PCR) amplification. Methotrexate-based systemic chemotherapy with external beam radiotherapy and intravitreal chemotherapy with methotrexate are useful for controlling the disease, but the prognosis remains poor. Therefore, it is important to make an early diagnose and treatment. This review is focused on the clinical manifestations, diagnosis, treatment and prognosis of the IOL.

Citing Articles

Neurosurgical Management of Central Nervous System Lymphoma: Lessons Learnt from a Neuro-Oncology Multidisciplinary Team Approach.

Velicu M, Lavrador J, Sibtain N, Vergani F, Bhangoo R, Gullan R J Pers Med. 2023; 13(5).

PMID: 37240953 PMC: 10221289. DOI: 10.3390/jpm13050783.


An Elderly Man with Atypical Multiple Evanescent White Dot Syndrome.

Wang L, Lankry P, Rabinovitch D, Gallo R, Laiginhas R, Iyer P Case Rep Ophthalmol. 2022; 13(3):892-896.

PMID: 36466057 PMC: 9710463. DOI: 10.1159/000526583.


Value of Combined Diagnosis for Choroidal Lymphoma: A Case Report.

Yang M, Zhang T, Yan B, Huang Y Curr Oncol. 2022; 29(11):8835-8845.

PMID: 36421348 PMC: 9689627. DOI: 10.3390/curroncol29110695.


Diagnostic Accuracy of Vitreous Cytology in Patients with Vitreoretinal Lymphoma.

Lee D, Lee J, Nahm J, Kim M J Clin Med. 2022; 11(21).

PMID: 36362676 PMC: 9656894. DOI: 10.3390/jcm11216450.


MALT Lymphoma Presenting with Peripheral Ulcerative Keratitis.

Patil S, Colby K, Lazzaro D Int Med Case Rep J. 2022; 15:485-490.

PMID: 36120701 PMC: 9477148. DOI: 10.2147/IMCRJ.S361865.


References
1.
Gill M, Jampol L . Variations in the presentation of primary intraocular lymphoma: case reports and a review. Surv Ophthalmol. 2001; 45(6):463-71. DOI: 10.1016/s0039-6257(01)00217-x. View

2.
Korfel A, Schlegel U . Diagnosis and treatment of primary CNS lymphoma. Nat Rev Neurol. 2013; 9(6):317-27. DOI: 10.1038/nrneurol.2013.83. View

3.
Chaput F, Amer R, Baglivo E, Touitou V, Kozyreff A, Bron D . Intraocular T-cell Lymphoma: Clinical Presentation, Diagnosis, Treatment, and Outcome. Ocul Immunol Inflamm. 2016; 25(5):639-648. DOI: 10.3109/09273948.2016.1139733. View

4.
Isobe K, Ejima Y, Tokumaru S, Shikama N, Suzuki G, Takemoto M . Treatment of primary intraocular lymphoma with radiation therapy: a multi-institutional survey in Japan. Leuk Lymphoma. 2006; 47(9):1800-5. DOI: 10.1080/10428190600632881. View

5.
Peterson K, Gordon K, Heinemann M, DeAngelis L . The clinical spectrum of ocular lymphoma. Cancer. 1993; 72(3):843-9. DOI: 10.1002/1097-0142(19930801)72:3<843::aid-cncr2820720333>3.0.co;2-#. View